Antifungal agents: New approach for novel delivery systems

Journal of Pharmaceutical Sciences and Research

Volumn 6, Issue 5, 2014, Pages 229-235

  Kumar, Jaya Raja ^a   Muralidharan, Selvadurai ^a   Parasuraman, Subramani ^a  

^a AIMST UNIVERSITY   (Malaysia)

Author keywords

Buccal gel; Micoemulsion; Mucoadhesive tablets; Nanoparticles; Nanosuspensions; Niosomes; Transdermal films

Indexed keywords

10 UNDECENOIC ACID; ALLYLAMINE DERIVATIVE; ANIDULAFUNGIN; ANTIFUNGAL AGENT; BUTOCONAZOLE; CASPOFUNGIN; CICLOPIROX; ECONAZOLE; FLUCONAZOLE; FLUCYTOSINE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; OXICONAZOLE; POSACONAZOLE; PYRROLE DERIVATIVE; SULCONAZOLE; TERBINAFINE; TERCONAZOLE; TIOCONAZOLE; TRIAZOLE; VORICONAZOLE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG STRUCTURE;

EID: 84928198971     PISSN: None     EISSN: 09751459     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Rai VK, Yadav NP, Sinha P, Mishra N, Luqman S, Dwivedi H, Kymonil KM, et al. Development of cellulosic polymer based gel of novel ternary mixture of miconazole nitrate for buccal delivery. Carbohydr Polym. 2014-15;103:126-33
2. Ofokansi KC, Kenechukwu FC, Ogwu NN. Design of novel miconazole nitrate transdermal films based on Eudragit RS100 and HPMC hybrids: preparation, physical characterization, in vitro and ex vivo studies.. Drug Deliv. 2014 Jan 23.
3. Carmona-Ribeiro AM. Preparation and characterization of biomimetic nanoparticles for drug delivery. Methods Mol Biol. 2012;906:283-94
4. Vazquez JA, Sobel JD. Miconazole mucoadhesive tablets: a novel delivery system. Clin Infect Dis. 2012; 54 (10):1480-4.
5. Mandal TK. Swelling-controlled release system for the vaginal delivery of miconazole. Eur J Pharm Biopharm. 2000; 50 (3):337-43.
6. Ana M. Cerdeira, Marco Mazzotti, Bruno Gander. Formulation and drying of miconazole and itraconazole nanosuspensions. International Journal of Pharmaceutics, Volume 443, Issues 1–2, 25 2013, Pages 209-220.
7. Chun-Wah Marcus Yuen, Joanne Yip, Liwei Liu, Kevin Cheuk, et al. Chitosan microcapsules loaded with either miconazole nitrate or clotrimazole, prepared via emulsion technique. Carbohydrate Polymers, Volume 89, Issue 3, 2012, Pages 795-801
8. Pedersen M and Rassing MR, “Miconazole Chewing Gum as a Drug. Delivery System Test of Release-Promoting Additives,”Drug Dev. Ind. Pharm. 17 (3), 411–420 (1991).
9. Mohamed Firthouse PU, Mohamed Halith S, Wahab SU. Formulation and Evaluation of Miconazole. Niosomes International Journal of PharmTech Research 2011. 3, No.2, 1019-1022.
10. Mangesh R Bhalekar, Varsha Pokharkar, Ashwini Madgulkar, Nilam Patil, etal. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech 2009; 10 (1):289-96.
11. Rahul Nair, Sevukarajan, Badivaddin Mohammed, Jaya Raj Kumar. Formulation of Microemulsion based vaginal gel-in vitro and in vivo evaluation. Der Pharmacia Lettre 01/2010; 2 (6):99-105.
12. Shumin Ge, Yuanyuan Lin, Haoyang Lu, Qi Li, Jian He, Bao Chen, et al. Percutaneous delivery of econazole using microemulsion as vehicle: Formulation, Evaluation and vesicle-skin
13. International Journal of Pharmaceutics, Volume 465, Issues 1–2, 25 April 2014, Pages 120-131
14. Deboroh Evelyn, Chuah Chong Wooi, Jaya Raja Kumar, Selvadurai Muralidharan and Sokkalingam Arumugam Dhanaraj.Development and evaluation of microemulsion based gel (MBGs) containing econazole nitrate for nail fungal infection. Journal of Pharmacy Research Vol.5 Issue 4.April 2012
15. Georgi Yordanov. Influence of the preparation method on the physicochemical properties of econazole-loaded poly (butyl cyanoacrylate) colloidal nanoparticles. Physicochemical and Engineering Aspects, Volume 413, 5 November 2012, Pages 260-265
16. Beatrice Albertini, Nadia Passerini, Marcello Di Sabatino, et al. Polymer–lipid based mucoadhesive microspheres prepared by spraycongealing for the vaginal delivery of econazole nitrate. European Journal of Pharmaceutical Sciences, Volume 36, Issues 4–5, 2 March 2009, Pages 591-601
17. Dellenbach P, Thomas JL, Guerin V, Ochsenbein E, Contet-Audonneau N. Topical treatment of vaginal candidosis with sertaconazole and econazole sustained-release suppositories. International Journal of Gynecology & Obstetrics, Volume 71, Supplement 1, December 2000, Pages 47-52
18. Kapadia MM1, Solanki ST, Parmar V, Thosar MM, Pancholi SS. Preliminary investigation tests of novel antifungal topical aerosol. J Pharm Bioallied Sci. 2012 Mar;4(Suppl 1):S74-6.
19. Parodi B, Russo E, Caviglioli G, Baldassari S, Gaglianone N, Schito AM, Cafaggi S. A chitosan lactate/poloxamer 407-based matrix containing Eudragit RS microparticles for vaginal delivery of econazole: Design and in vitro evaluation. Drug Dev Ind Pharm. 2013 Dec;39 (12):1911-20
20. Baloglu E, Karavana SY, Senyigit ZA, Hilmioglu-Polat S, Metin DY, et al. In-situ gel formulations of econazole nitrate: preparation and in-vitro and in-vivo evaluation. J Pharm Pharmacol. 2011 Oct; 63(10):1274-82.
21. Baloglu E, Ay Senyıgıt Z, Karavana SY, Vetter A, Metın DY, et al. In vitro evaluation of mucoadhesive vaginal tablets of antifungal drugs prepared with thiolated polymer and development of a new dissolution technique for vaginal formulations. Chem Pharm Bull (Tokyo). 2011;59 (8):952-8.
22. Sosto F, Benvenuti C; CANVA Study Group. Controlled study on thymol + eugenol vaginal douche versus econazole in vaginal candidiasis and metronidazole in bacterial vaginosis. Arzneimittelforschung. 2011;61(2):126-31.
23. Cogswell S, Berger S, Waterhouse D, Bally MB, Wasan EK. A parenteral econazole formulation using a novel micelle-to-liposome transfer method: in vitro characterization and tumor growth delay in a breast cancer xenograft model. Pharm Res. 2006 Nov;23 (11):2575-85.Epub 2006 Sep 13.
24. Milano J, Cardoso SG. Spectrophotometric determination of oxiconazole in topical lotion using methyl orange. J Pharm Biomed Anal. 2005 Apr 1;37 (4):639-42.
25. Eric J. Benjamin, Maryann Lee, John Tom, Lin Lih-Yang, Maida Henesian, Wu Diana. Stabilization of sulconazole nitrate in a topical powder formulation.International Journal of Pharmaceutics Volume 14, Issues 2–3, April 1983, Pages 209–221
26. Tulli A, Leone E, De Simone C. Tioconazole 1% powder in the treatment of dermatomycoses. Clin Ter. 1988 Sep 30; 126(6):417-20.
27. Das S, Ng WK, Tan RB. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations. Nanotechnology. 2014 Mar 14;25(10):105102.
28. Maltas E, Ozmen M, Yildirimer B, Kucukkolbasi S, Yildiz S. Interaction between ketoconazole and human serum albumin on epoxy modified magnetic nanoparticles for drug delivery. J Nanosci Nanotechnol. 2013 Oct;13(10):6522-8.
29. Hafeez F, Hui X, Chiang A, Hornby S, Maibach H. Transungual delivery of ketoconazole using novel lacquer formulation. Int J Pharm. 2013 Nov 18;456 (2):357-61.
30. Shirsand S, Para M, Nagendrakumar D, Kanani K, Keerthy D. Formulation and evaluation of Ketoconazole niosomal gel drug delivery system. Int J Pharm Investig. 2012 Oct; 2(4):201-7.
31. Rajan R, Vasudevan DT. Effect of permeation enhancers on the penetration mechanism of transfersomal gel of ketoconazole. J Adv Pharm Technol Res. 2012 Apr; 3(2):112-6.
32. Modi J, Joshi G, Sawant K. Chitosan based mucoadhesive nanoparticles of ketoconazole for bioavailability enhancement: formulation, optimization, in vitro and ex vivo evaluation. Drug Dev Ind Pharm. 2013 Apr; 39(4):540-7.
33. Patel MR, Patel RB, Parikh JR, Solanki AB, Patel BG. Investigating effect of microemulsion components: In vitro permeation of ketoconazole. Pharm Dev Technol. 2011 Jun;16 (3):250-8.
34. Wang L, Tang X. A novel ketoconazole bioadhesive effervescent tablet for vaginal delivery: design, in vitro and 'in vivo' evaluation. Int J Pharm. 2008 Feb 28;350 (1-2):181-7.
35. Karasulu HY, Taneri F, Sanal E, Güneri T, Ertan G. Sustained release bioadhesive effervescent ketoconazole microcapsules tabletted for vaginal delivery. J Microencapsul. 2002 May-Jun; 19(3):357-62.
36. Zheng WS, Fang XQ, Wang LL, Zhang YJ. Preparation and quality assessment of itraconazole transfersomes. Int J Pharm. 2012 Oct 15; 436 (1-2):291-8.
37. Dobaria NB, Badhan AC, Mashru RC. A novel itraconazole bioadhesive film for vaginal delivery: design, optimization, and physicodynamic characterization. AAPS PharmSciTech. 2009;10 (3):951-9.
38. Mohanty B, Majumdar DK, Mishra SK, Panda AK, Patnaik S. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery. Pharm Dev Technol. 2014 Feb 4.
39. Kim JY, Rhee YS, Park CW, Ha JM, Park ES. Preparation and evaluation of dual-mode floating gastroretentive tablets containing itraconazole. Drug Deliv. 2013 Nov 18.
40. Segale L, Giovannelli L, Mannina P, Pattarino F. Formulation and characterization study of itraconazole-loaded microparticles. Pharm Dev Technol. 2013 Nov 13.
41. Wagh VD, Deshmukh OJ. Itraconazole Niosomes. Drug Delivery System and Its Antimycotic Activity against Candida albicans. ISRN Pharm. 2012; 2012:653465.
42. Chudasama A, Patel V, Nivsarkar M, Vasu K, Shishoo C. Investigation of microemulsion system for transdermal delivery of itraconazole. J Adv Pharm Technol Res. 2011 Jan; 2(1):30-8.
43. Liu P, Rong X, Laru J, van Veen B, Kiesvaara J, Hirvonen J, Laaksonen T, Peltonen L. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. Int J Pharm. 2011 Jun 15; 411(1-2):215-22.
44. Jaya raja Kumar K, Jayachandran E, Srinivas GM, Giridhar B, et al. Formulation of thermoresponsive and buccal adhesive in situ gel for treatment of oral thrush containing itraconazole, J. Pharm. Sci. & Res. Vol.2(2), 2010, 116-122
45. Sarnes A, Kovalainen M, Häkkinen MR, Laaksonen T, Laru J, et al. Nanocrystal-based per-oral itraconazole delivery: Superior in vitro dissolution enhancement versus Sporanox® is not realized in in vivo drug absorption. J Control Release. 2014 Apr 28; 180:109-16.
46. Li DX, Park YJ, Oh DH, Joe KH, Lee JH, Yeo WH, Yong CS, Choi HG. J Pharm Pharmacol. Development of an itraconazole-loaded gelatin microcapsule with enhanced oral bioavailability: physicochemical characterization and in-vivo evaluation.2010 Apr;62 (4):448-55. doi: 10.1211/jpp/62.04.0006.
47. Chen W, Zhan C, Gu B, Meng Q, Wang H, Lu W, Hou H. Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles. J Drug Target. 2011 Apr; 19(3):228-34.
48. Tang J, Wei H, Liu H, Ji H, Dong D, Zhu D, Wu L. Pharmacokinetics and biodistribution of itraconazole in rats and mice following intravenous administration in a novel liposome formulation. Drug Deliv. 2010 May; 17(4):223-30.
49. Madgulkar A, Kadam S, Pokharkar V. Studies on formulation development of mucoadhesive sustained release itraconazole tablet using response surface methodology. AAPS PharmSciTech. 2008;9(3):998-1005
50. Gandra SC, Nguyen S, Nazzal S, Alayoubi A, Jung R, Nesamony J. Thermoresponsive fluconazole gels for topical delivery: rheological and mechanical properties, in vitro drug release and anti-fungal efficacy. Pharm Dev Technol. 2013 Oct 25.
51. Jaya Raj Kumar K, Jayachandran E, Srinivas GM, Giridhar B, Rahul Nair, et al. A Novel Thermo-Sensitive Sol-Gel Reversible Buccal Adhesive Property of Fluconazole in Situ Gel For Oral Thrush. J Biomed Sci and Res., Vol 2 (2), 2010,100-109
52. Jaya Raja Kumar K, Selvadurai Muralidharan, Sokkalingam Arumugam Dhanaraj. Development and in vitro Evalution of Guar Gum based Fluconazole in situ Gel for Oral Thrush Journal of Pharmaceutical Sciences & Research; 2012, Vol. 4 Issue 12, p2009
53. Mohammed N, Rejinold NS, Mangalathillam S, Biswas R, Nair SV, Jayakumar R. Fluconazole loaded chitin nanogels as a topical ocular drug delivery agent for corneal fungal infections. J Biomed Nanotechnol. 2013 Sep; 9 (9):1521-31.
54. Nirmala MJ, Mukherjee A, Chandrasekaran N. Improved efficacy of fluconazole against candidiasis using bio-based microemulsion technique. Biotechnol Appl Biochem. 2013 Jul-Aug; 60 (4):417-29.
55. Gupta M, Vyas SP. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids. 2012 May; 165(4):454-61.
56. Gupta M, Vaidya B, Mishra N, Vyas SP. Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery. Artif Cells Blood Substit Immobil Biotechnol. 2011 Dec; 39(6):376-84.
57. Habib FS, Fouad EA, Abdel-Rhaman MS, Fathalla D. Liposomes as an ocular delivery system of fluconazole: in-vitro studies. Acta Ophthalmol. 2010 Dec; 88(8):901-4.
58. Bhalaria MK, Naik S, Misra AN. Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases. Indian J Exp Biol. 2009 May;47 (5):368-75.
59. Gohel MC, Nagori SA. Fabrication and design of transdermal fluconazole spray. Pharm Dev Technol. 2009; 14(2):208-15.
60. Maiti S, Dey P, Kaity S, Ray S, Maji S, Sa B. Investigation on processing variables for the preparation of fluconazole-loaded ethyl cellulose microspheres by modified multiple emulsion technique. AAPS PharmSciTech. 2009; 10 (3):703-15.
61. Bachhav YG, Patravale VB. Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. Int J Pharm. 2009 Jan 5;365 (1-2):175-9.
62. Soriano I, Martín AY, Evora C, Sánchez E. Biodegradable implantable fluconazole delivery rods designed for the treatment of fungal osteomyelitis: influence of gamma sterilization. J Biomed Mater Res A. 2006 Jun 1;77(3):632-8.
63. Kumar R, Sinha VR. Preparation and optimization of voriconazole microemulsion for ocular delivery. Colloids Surf B Biointerfaces. 2014 Feb 15; 117C:82-88.
64. Miller RB, McLaren AC, Pauken C, Clarke HD, McLemore R. Voriconazole is delivered from antifungal-loaded bone cement. Clin Orthop Relat Res. 2013 Jan; 471(1):195-200.
65. Sinha B, Mukherjee B, Pattnaik G. Poly-lactide-co-glycolide nanoparticles containing voriconazole for pulmonary delivery: in vitro and in vivo study. Nanomedicine. 2013 Jan;9(1):94-104.
66. Song CK, Balakrishnan P, Shim CK, Chung SJ, Chong S, Kim DD. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces. 2012 Apr 1; 92:299-304.
67. El-Hadidy GN, Ibrahim HK, Mohamed MI, El-Milligi MF. Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation. Drug Dev Ind Pharm. 2012 Jan; 38(1):64-72.
68. Pawar P, Kashyap H, Malhotra S, Sindhu R. Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment. Biomed Res Int. 2013; 2013:341218.
69. Xiang-Gen W, Li-Na Y, Meng X, Hao-Ran J. Anti-infectious activity of intravitreal injectable voriconazole microspheres on experimental rabbit fungal endophthalmitis caused by Aspergillus fumigatus. J Pharm Sci. 2011 May; 100(5):1745-59.
70. Celebi N, Ermiş S, Ozkan S. Development of topical hydrogels of terbinafine hydrochloride and evaluation of their antifungal activity. Drug Dev Ind Pharm. 2014 Feb 27.
71. Angamuthu M, Nanjappa SH, Raman V, Jo S, Cegu P, Murthy SN. Controlled-release injectable containing Terbinafine/PLGA microspheres for Onychomycosis Treatment. J Pharm Sci. 2014 Apr; 103(4):1178-83.
72. Sudhakar B, Varma JN, Murthy KV. Formulation, Characterization and Ex vivo studies of Terbinafine HCl Liposomes for Cutaneous Delivery. Curr Drug Deliv. 2014 Jan 8.
73. Vaghasiya H, Kumar A, Sawant K. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride. Eur J Pharm Sci. 2013 May 13; 49 (2):311-22.
74. Wavikar P, Vavia P. Nanolipidgel for enhanced skin deposition and improved antifungal activity. AAPS PharmSciTech. 2013 Mar; 14 (1):222-33.
75. Sigurgeirsson B, Ghannoum M. Therapeutic potential of TDT 067 (terbinafine in Transfersome): a carrier-based dosage form of terbinafine for onychomycosis. Expert Opin Investig Drugs. 2012 Oct; 21(10):1549-62.
76. Barot BS, Parejiya PB, Patel HK, Gohel MC, Shelat PK. Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using D-optimal design. AAPS PharmSciTech. 2012 Mar; 13(1):184-92.